siRNA, Anti-CD5, 2'-OMe/2'-MOE/LNA/Ribo/Backbone-modified(CAT#: SIRGT01625WQ-2OMe)

The product SIRGT01625WQ-2OMe is a type of small interfering RNA (siRNA) that targets CD5 gene and regulates the expression of gene. The siRNA interferes with the expression of CD5 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_001346456.1; NM_014207.3
Alternative Names LEU1; T1
Related Diseases Richter's Syndrome, Thymic Carcinoma
Purification HPLC
Target Gene
Gene ID 921
Uniprot ID P06127
Sub Cat Target Species Modification Scale  
SIRGT03625WQ-2MOE CD5 Human 2'-O-methoxyethyl (2'-MOE) Inquiry
SIRGT04625WQ-LNA CD5 Human Locked Nucleic Acid (LNA) Inquiry
SIRGT01625WQ-RB CD5 Human Ribo-modified Inquiry
SIRGT02625WQ-BB CD5 Human Backbone-modified Inquiry

Related Products